Welcome to our dedicated page for Cypherpunk Technologies SEC filings (Ticker: CYPH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cypherpunk Technologies Inc. filings document the company’s transition from Leap Therapeutics, its Zcash-focused digital asset treasury strategy, and its continuing biopharma subsidiary activities. Form 8-K reports cover financial results, material agreements, warrant modifications connected to private placement financing, equity incentive plan approvals, and exchange-listing compliance notices.
Proxy materials describe annual meeting matters, board composition, stockholder voting procedures, executive compensation governance, and equity plan authorization. The filing record also reflects capital-structure disclosures involving common stock, warrants, and incentive plan shares, along with governance changes related to director retirements and committee service.
Cypherpunk Technologies reported a much larger net loss for the first quarter of 2026 as its Zcash-focused digital asset strategy faced a sharp price drop. Net loss was $77.2 million for the quarter ended March 31, 2026, compared with $15.4 million a year earlier, driven mainly by a $77.6 million unrealized loss on the fair value of its ZEC treasury holdings as ZEC fell from $508.09 to $240.47.
Operating expenses shifted significantly, with research and development dropping to $0.2 million from $12.9 million as clinical trials were completed, while general and administrative expenses rose to $4.7 million from $3.0 million due largely to RSU-based compensation. Cash and cash equivalents were $6.7 million on March 31, 2026, and ZEC treasury holdings classified as digital assets receivable were valued at $73.8 million based on the quarter-end ZEC price.
Cypherpunk Technologies Inc. reported a Q1 2026 net loss of $77.2M, driven mainly by a $77.6M unrealized loss on the change in fair value of an embedded derivative tied to its Zcash (ZEC) digital asset receivable. Operating expenses fell sharply as research and development dropped to $0.2M from $12.9M after winding down clinical programs, while general and administrative costs rose to $4.7M on higher stock-based compensation and professional fees. Cash and cash equivalents were $6.7M and ZEC holdings were valued at $73.8M as of March 31, 2026, with an accumulated deficit of $539.7M. Management believes existing liquidity plus capacity under a $200M at-the-market program is sufficient to fund operations for at least 12 months, though a previously identified material weakness in internal control over financial reporting remains unremediated.
Cypherpunk Technologies Inc. is asking stockholders to vote at its all-virtual 2026 Annual Meeting on June 18, 2026. Holders of 97,678,728 shares of common stock as of April 29, 2026 may participate and vote online.
Investors are being asked to elect two Class III directors, Nissim Mashiach and Will McEvoy, to terms running through 2029, approve an advisory "Say-on-Pay" vote on executive compensation, and ratify EisnerAmper LLP as independent auditors for 2026. Several long-time directors, including Joseph Loscalzo, Christopher Mirabelli, James Cavanaugh and Richard Schilsky, will leave the board around the meeting, after which eight directors will remain.
The proxy details a virtual-only format with internet, telephone, mail and online meeting voting options, explains the company’s governance structure and committee independence, and outlines 2025 pay for key executives, including CEO Douglas Onsi and new Chief Investment Officer Will McEvoy, whose packages combine salary with significant equity-based awards.
Cypherpunk Technologies Inc. reports that four long-serving directors plan to retire from its Board in connection with the 2026 Annual Meeting of Stockholders. On April 7, 2026, Dr. Christopher Mirabelli and Dr. Joseph Loscalzo submitted resignations effective immediately prior to the 2026 Annual Meeting and will not stand for re-election as Class III directors. On the same date, Dr. Richard Schilsky and Dr. James Cavanaugh notified the company of their intent to retire as Class I directors, also effective immediately prior to the 2026 Annual Meeting. The company states that none of these departures result from any disagreement regarding operations, policies, or practices, and the Board expresses appreciation for each director’s years of service.
CYPHERPUNK TECHNOLOGIES INC. director Christopher Mirabelli reported an open-market sale of 60,000 shares of Common Stock at an average price of $0.7105 per share on March 26, 2026. According to the footnote, the sale was made to cover estimated taxes related to a previously reported settlement of RSUs on March 13, 2026. After this transaction, Mirabelli directly owns 130,376 shares of the company’s common stock.
Cypherpunk Technologies Inc. director Dietz Thomas John exercised previously granted equity awards and increased his direct common share holdings. On March 13, 2026, 104,500 Restricted Stock Units granted on December 23, 2025 under the 2025 Equity Incentive Plan were settled on a 1-for-1 basis into 104,500 shares of common stock for no cash consideration. These RSUs had vested at issuance. Following the settlement, he directly holds 152,500 shares of Cypherpunk Technologies common stock and no remaining RSU position from this grant.
Cypherpunk Technologies Inc. director Christopher Mirabelli exercised restricted stock units into common shares as part of his equity compensation. On March 13, 2026, he settled 74,700 RSUs granted on November 11, 2025 and 94,050 RSUs granted on December 23, 2025 on a 1-for-1 basis into common stock at $0.00 per share. Both RSU grants had vested at issuance. Following these conversions, he directly holds 190,376 shares of common stock and has no remaining derivative positions from these RSUs.
Cypherpunk Technologies Inc. director Oei Khing Djien increased his direct holdings through the settlement of previously granted restricted stock units. On March 13, 2026, 74,700 RSUs granted on November 11, 2025 and 94,050 RSUs granted on December 23, 2025 were settled 1-for-1 into common shares for no cash consideration. Both RSU grants had vested at issuance. Following these derivative exercises/conversions, he directly holds 168,750 shares of common stock.